0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query marketline 3sbio inc mergers acquisitions ma partnerships alliances investment report.Your search for "" gave back 1533064 results.
The global Postmenopausal Breast Cancer Treatment Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Recombinant Human Erythropoietin for Injection market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size...
Catalog:
GIR
December 2023
Price: USD 3,480.00
The global Short-acting Recombinant Human Erythropoietin Drugs market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted...
Catalog:
GIR
October 2023
Price: USD 3,480.00
The global Short-acting EPO Drugs market size was valued at USD 9445.8 million in 2022 and is forecast to a readjusted size of USD 14140 million by...
Catalog:
GIR
October 2023
Price: USD 3,480.00
The global Macromolecule Biopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
December 2023
Price: USD 3,480.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Antibody and Recombinant Protein CDMO market will undergo...
Catalog:
Arsta
April 2022
Price: USD 3,360.00
Retinal Vein Occlusion - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Antibody and Recombinant Protein CDMO market will undergo...
Catalog:
Arsta
August 2022
Price: USD 3,360.00
Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report...
MarketLine
March 2022
Price: USD 175.00
Choroidal Neovascularization - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Ubiquitin Enzymes market will undergo major changes...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
Regal Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report Summary Regal Real Estate Investment Trust - Strategy, SWOT and...
MarketLine
November 2021
Price: USD 175.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
